Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study

Antti P. Salminen, Ilmari Koskinen, Ileana Montoya Perez, Saija Hurme, Teemu J. Murtola, Markku H. Vaarala, Timo K. Nykopp, Marjo Seppänen, Taina Isotalo, Timo Marttila, Lasse Levomäki, Sebastian Becker, Mikael Anttinen, Tapani Liukkonen, Matti Säily, Dimitri Pogodin-Hannolainen, Jouko Viitanen, Christian Palmberg, Juhani Ottelin, Jukka SairanenOtto O. Ettala, Peter J. Boström

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean urology oncology
Volume1
Issue number6
Pages (from-to)525-530
Number of pages6
ISSN2588-9311
DOIs
Publication statusPublished - Dec 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Bladder cancer
  • Neoadjuvant chemotherapy
  • Radical cystectomy
  • Complication
  • Morbidity
  • Mortality
  • INVASIVE BLADDER-CANCER
  • PHASE-III
  • UROTHELIAL CARCINOMA
  • OPEN-LABEL
  • METHOTREXATE
  • VINBLASTINE
  • CISPLATIN
  • DOXORUBICIN
  • COMPLICATIONS
  • GEMCITABINE
  • 3126 Surgery, anesthesiology, intensive care, radiology
  • 3122 Cancers

Cite this

Salminen, A. P., Koskinen, I., Perez, I. M., Hurme, S., Murtola, T. J., Vaarala, M. H., Nykopp, T. K., Seppänen, M., Isotalo, T., Marttila, T., Levomäki, L., Becker, S., Anttinen, M., Liukkonen, T., Säily, M., Pogodin-Hannolainen, D., Viitanen, J., Palmberg, C., Ottelin, J., ... Boström, P. J. (2018). Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study. European urology oncology, 1(6), 525-530. https://doi.org/10.1016/j.euo.2018.06.014